Atazanavir Sulfate; Cobicistat Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Atazanavir Sulfate; Cobicistat Tablet (tablet) from Bristol Myers Squibb Co. with status To Be Discontinued. The shortage was first posted on 11/03/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- Bristol Myers Squibb Co.
- Package NDC
- 0003-3641-11
- Dosage Form
- Tablet
- Presentation
- Evotaz, Tablet, 300 mg; 150 mg (NDC 0003-3641-11)
- Initial Posting
- 11/03/2025
- Revised Date